We are using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience.

By continuing to use our website without changing the settings, you are agreeing to our use of cookies.

Find out more
You are here:
> > > > > Research and new developments in pregnancy and arthritis

Research and new developments in pregnancy and arthritis

Our understanding of biological therapies and newer immunosuppressive drugs is growing. For instance, in the UK the British Society of Rheumatology (BSR) is gathering information on over 16,000 patients treated with adalimumabetanercept and infliximab in a biologics registry (called the BSRBR) to examine the safety of these drugs.

Information from this registry on patients who continue taking these drugs while pregnant or breastfeeding will allow doctors to better determine their safety in these circumstances. There is, however, still an urgent need for studies clarifying the risk of anti-rheumatic drugs during breastfeeding and in men trying to father a child.


0800 5200 520

Our new helpline: Call us for free information, help and advice on your type of arthritis. Open Mon–Fri 9am–8pm.

All calls are recorded for training and quality purposes

Virtual Assistant

Our new Arthritis Virtual Assistant uses artificial intelligence to answer your arthritis related questions 24/7.

Ask a question
For more information, go to
Arthritis Research UK fund research into the cause, treatment and cure of arthritis. You can support Arthritis Research UK by volunteering, donating or visiting our shops.